Riskpilot← Back to searchSign inGet full accessBIOMÉRIEUX DENMARK ApS
APSActiveCVR 10062462Lautruphøj 1-3Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20019 employees
Revenue 2024
DKK 76,3M
+9% vs 2023
EBITDA margin
4.5%
+34% vs 2023
Equity ratio
31.7%
Financial strength
Net profit 2024
DKK 2,7M
+27% vs 2023
| Revenue | DKK 76,3M | +9% |
| EBITDA | DKK 3,4M | +34% |
| Net profit | DKK 2,7M | +27% |
| Total assets | DKK 25,7M | +3% |
| Equity | DKK 8,2M | -3% |
| Employees | 9 | — |
Legal name
BIOMÉRIEUX DENMARK ApS
CVR number
10062462
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
19. januar 2001
Share capital
DKK 500.000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af en direktør.
Company purpose
Selskabets formål er produktion, køb, salg og marketing af diagnostikudstyr og hermed beslægtede produkter samt anden i forbindelse med disse formål stående virksomhed. Selskabets formål er herudover at eje kapitalandele i andre selskaber.
Address
Lautruphøj 1-3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 68.283 | 77.639 | 65.119 | 70.307 | 76.313 |
| Staff expenses | -8.144 | -8.033 | -7.656 | -7.740 | -7.285 |
| EBITDA | 4.613 | 6.713 | 4.789 | 2.564 | 3.424 |
| Depreciation & amort. | -162 | -154 | -154 | -138 | -69 |
| EBIT | 4.451 | 6.559 | 4.635 | 2.425 | 3.355 |
| Net financials | -173 | -180 | 29 | 375 | 184 |
| Profit before tax | 4.278 | 6.379 | 4.665 | 2.800 | 3.539 |
| Tax | 936 | 1.413 | 1.032 | 638 | 790 |
| Net profit | 3.342 | 4.966 | 3.632 | 2.163 | 2.749 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26.713 | 28.656 | 25.341 | 24.975 | 25.724 |
| Equity | 9.544 | 12.274 | 13.672 | 8.384 | 8.154 |
| Long-term debt | 758 | 0 | 0 | 0 | 0 |
| Short-term debt | 16.336 | 16.339 | 11.653 | 16.589 | 17.571 |
| Total debt | 17.094 | 16.339 | 11.653 | 16.589 | 17.571 |
EBITDA margin
4.5%
This company
15.8%
Market median
-72% vs market
20202024
Equity ratio
31.7%
This company
38.2%
Market median
+17% vs market
20202024
Return on equity
33.7%
This company
18.4%
Market median
+83% vs market
20202024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20202024
Asset turnover
2.97×
This company
1.12×
Market median
+165% vs market
20202024
Debt / equity
2.15×
This company
0.62×
Market median
-247% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (8) | ||
CF Management | Management | 2010 – 2011 |
AC Management | Management | 2008 – 2010 |
PR Management | Management | 2001 – 2004 |
JH | Audit | 2001 – 2012 |
AB Management | Management | 2004 – 2008 |
KS Management | Management | 2001 – 2001 |
JG Chief Executive Officer | Chief Executive Officer | 2015 – 2019 |
SL Management | Management | 2007 – 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2020 | |
| Chairman | 2023 | |
| Former (14) | ||
| Chairman | 2022 – 2023 | |
| Board of Directors | 2011 – 2020 | |
| Board of Directors | 2001 – 2001 | |
| Board of Directors | 2007 – 2010 | |
| Chairman | 2011 – 2015 | |
| Chairman | 2001 – 2001 | |
| Board of Directors | 2013 – 2021 | |
| Chairman | 2010 – 2011 | |
| Board of Directors | 2010 – 2011 | |
| Chairman | 2015 – 2019 | |
| Board of Directors | 2021 – 2024 | |
| Chairman | 2019 – 2022 | |
| Board of Directors | 2007 – 2011 | |
| Chairman | 2007 – 2010 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOMÉRIEUX DENMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cyril Francois Roger Chauvelle | Management | 0 companies |
| Arnaldo Cesare Marchionne | Management | 0 companies |
| Patrice Roger Charles Ancillon | Management | 0 companies |
| John Hauschildt Ladekarl | Audit | 0 companies |
| Arturo Bernardino Aire Dabura | Management | 0 companies |
| Klaus Søgaard | Management | 0 companies |
| Jean-Louis Georges Jacques Tissier | Chief Executive Officer | 0 companies |
| Sine Lut Hanne Holm | Management | 0 companies |
| Pascal Jean D Waucquez | Chairman | 0 companies |
| Sandrine Régine Flory | Board of Directors | 0 companies |
| Troels Elkiær Andersen | Board of Directors | 0 companies |
| Cyril Francois Roger Chauvelle | Board of Directors | 0 companies |
| Sascha Przybilla | Chairman | 0 companies |
| Jan-Erik Gunnar Svensson | Chairman | 0 companies |
| Veronique Comte | Board of Directors | 0 companies |
| Urszula Maria Leśniak | Board of Directors | 0 companies |
| Philippe Jean Marie Auriol | Chairman | 0 companies |
| Veroniqoe Audrey Comte | Board of Directors | 0 companies |
| Bertrand Playe | Board of Directors | 0 companies |
| Jean-Louis Georges Jacques Tissier | Chairman | 0 companies |
| Vincent Bruno Marciniak | Board of Directors | 0 companies |
| Rocio Mendez Aleman | Chairman | 0 companies |
| Emmanuel Paul Marie de Guibert | Board of Directors | 0 companies |
| Eric Marie Pierre Maillet | Chairman | 0 companies |
| Denis Bernard Monnaie | Chairman | 0 companies |